Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-24-004859
Filing Date
2024-02-14
Accepted
2024-02-14 17:27:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 primemedicine424b521424.htm 424B5 515457
2 primemedlogoa.jpg GRAPHIC 36675
3 prospectussuppsummary1aa.jpg GRAPHIC 513186
  Complete submission text file 0001628280-24-004859.txt   1272956
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275321 | Film No.: 24640781
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)